The Thalidomide Legacy by R W Smithells mRcP (Alder Hey Children's Hospital, Liverpool) Thalidomide first became available in Great Britain in 1958 and the first deformities caused by it appeared the following year. By the middle of 1960 thalidomide deformities had reached epidemic proportions and this situation persisted until August 1962 nine months after the drug had been withdrawn from the market.
The most frequent teratogenic effect is reduction deformity of the limbs but thalidomide can also malform the ears, the eyes, the heart, the bowels, the kidneys, the palate and the gallbladder. The nervous system, apart from the eye, is affected but rarely. This is interesting when it is recalled that the only conspicuous toxic effect of thalidomide other than embryopathy was peripheral neuritis.
Of all the non-limb malformations attributed to this drug the largest group consists of those affecting the ears. I shall leave Mr Livingstone to describe the anatomy of these ear deformities but for convenience I shall refer to them collectively as microtia. Microtia, like limb defects, is usually bilateral though not necessarily symmetrical. An associated ipsilateral facial palsy is common enough to be considered part of the same lesion and not a separate abnormality. So far as I know, facial palsy without ear deformity has never been attributed to thalidomide.
It has been estimated that about 10% of all children born with thalidomide limb defects also had malformed ears. Many of these infants had lethal internal deformities and the incidence of microtia amongst survivors is therefore lower. Microtia with normal limbs was two or three times as common as microtia with limb defects. These figures are of some help in trying to estimate the total numbers of affected children.
The highest incidence of thalidomide deformities was in West Germany, where the drug was first manufactured and was widely available without prescription: the number of babies born there with reduction deformities of the limbs has been 34 Papers estimated at about 5,000 (British Medical Journal 1962) . A recent review of microtia in West Germany (Kleinsasser & Schlothane 1964) suggests that at least 1,000 affected children were born in that country.
In Great Britain the number of children born with limb defects caused by thalidomide was estimated by Leck & Millar (1962) to be about 800. I reached a similar conclusion independently (Smithells 1962) . The survey of deformities caused by thalidomide recently published by the Ministry of Health (1964) concludes that there are probably between 200 and 250 children alive with thalidomide-induced limb defects. The disparity between the Ministry figures and those of the earlier reports is more apparent than real. Stillbirths and early deaths are fully covered by the larger estimates but not by the Ministry survey. The estimates are much closer when allowance is made for the fact that between a third and a half of all affected children died at or soon after birth. Add to this the difficulty of establishing whether or not a mother had taken thalidomide, and the remaining discrepancy becomes insignificant. I have little doubt that some of the children in the survey were deformed by thalidomide in spite of a negative history and that the true figure for thalidomide-damaged survivors with limb deformities is in the region of 350. About 1 in 15 or 1 in 20 of these children could be expected to have microtia also; in fact the survey records 17 with limb and ear defects.
Irrespective of the state of the limbs, 74 children with ear defects are recorded whose mothers certainly or probably took thalidomide. Of these 74, 54 were alive at the time of the survey. The Ministry only recorded information about children with non-limb defects if their mothers had taken thalidomide. Bearing in mind the difficulties of obtaining an accurate thalidomide history, the true number of children with druginduced microtia may be as great as twice the Ministry figuresay 150 altogether, including stillbirths and early deaths. However, I would expect many of the missed cases to be amongst these perinatal losses and the Ministry estimate of survivors is probably close to the truth. 492 Proceedings ofthe Royal Society ofMedicine 14 I should now like to consider the malformations that may be associated with microtia. The children we are discussing may come under the care of a specialist concerned with one part of the body and there is a danger that a malformation elsewhere may be overlooked. For example, we have recently seen in Liverpool a child whose limb defects had been expertly supervised for four years at a limb-fitting centre elsewhere; he was referred to us for the provision of gas-powered arms and was found to have a patent ductus arteriosus. Not only did this need attention on its own merits but also his heart lesion was limiting his exercise tolerance and thereby slowing his progress with artificial limbs.
The abnormalities most frequently seen with microtia are those of the limbs but these are in no danger of being overlooked; they occur in about one-third of survivors. The next most common associated defect is congenital heart disease and this can very easily be overlooked. Of the 54 survivors with microtia in the Ministry survey, no less than 9 are recorded as having congenital heart disease. The incidence of heart defects in dead children was much higherabout 50%and these lesions were responsible for many of the deaths. Thalidomide is a broad-spectrum teratogen and seems to be capable of causing almost any congenital heart lesion. Knowledge of the cause is no help in differential diagnosis.
The next most common anomalies to be associated with microtia are those of the bowel. These are predominantly obstructive lesions and have therefore either been fatal or have been treated surgically at birth. Lesions of the eye occur almost as frequently but the deformities most commonly seen, microphthalmos and coloboma, are obvious enough.
Finally, mention should be made of the renal tract. Amongst children with ear defects who were dead at the time of the Ministry survey, onethird had lesions of the kidney. In only one of these cases was the renal lesion likely to have caused death. This makes it probable that renal tract anomalies are present in a number of survivorsalmost certainly in more than the 2 cases recorded in the survey.
The associations between abnormalities of the ear, eye and heart on the one hand and of the ear and kidney on the other are not, of course, confined to thalidomide embryopathy. Rubella affects principally the ear, the eye and the heart. In mongolism, there is often a characteristic deformity of the pinna, Brushfield spots are usual, cataract occasional and congenital heart disease common. Ear, eye and heart deformities are described in the other autosomal trisomies. In Marfan's syndrome defects of the heart and eye are common and the ears may be large and poorly cartilaginized. In the rarer oculo-auriculovertebral syndrome, deformities of the ear and large pre-auricular skin tags are associated with conjunctival dermoids and other anomalies including congenital heart disease. The classical association between the ears and the kidneys is seen in renal agenesis with Potter facies but a broader relationship exists. As Hilson (1957) pointed out, abnormalities of the pinna may be associated with congenital hydronephrosis and other renal anomalies. It is of interest that with unilateral renal defects often only the ear on the same side is abnormal.
The role of the poediatrician in the care of children damaged by thalidomide is essentially one of co-ordinating the special skills of his colleagues and the facilities provided by statutory and voluntary bodies into a unified and progressive programme. This is a need common to all handicapped children. The thalidomide children share this need, but stand apart in two important respects.
First, they are potential candidates for a very wide diversity of congenital anomalies. Most survivors, it is true, have limb defects only, but amongst the group with microtia some have limb defects, some have cardiac defects, some have eye abnormalities and a few have abnormal kidneys. It is essential that these lesions should be recognized and receive the same expert attention that is being given to their ears.
Second, the parents of these children are, as a group, in some ways unique. Many of them are of professional and business families; the mothers were given thalidomide principally for anxiety or insomnia and somewere under psychiatric care during pregnancy. Finally, the guilt feelings so common amongst the parents of deformed children are magnified a thousand times because these people know that their children's deformities resulted from something they did. Nothing we can say nor any form of litigation, whatever the outcome, is going to assuage their remorse. Microtia may not seem much of a handicap in comparison with virtual absence of the arms or legs but it is unsightly; deafness, if it cannot be relieved, is a burden; bilateral facial palsy is perhaps the hardest to bear. We must not be surprised if some of the parents of these children are anxious, inquisitive, impatient, at times critical and even aggressive; nor if they swing to the other extreme and insist that we can perform miracles.
